Your browser doesn't support javascript.
loading
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Ravandi, Farhad; Kreitman, Robert J; Tiacci, Enrico; Andritsos, Leslie; Banerji, Versha; Barrientos, Jacqueline C; Bhat, Seema A; Blachly, James S; Broccoli, Alessandro; Call, Timothy; Chihara, Dai; Dearden, Claire; Demeter, Judit; Dietrich, Sasha; Else, Monica; Epperla, Narendranath; Falini, Brunangelo; Forconi, Francesco; Gladstone, Douglas E; Gozzetti, Alessandro; Iyengar, Sunil; Johnston, James B; Jorgensen, Jeffrey; Juliusson, Gunnar; Lauria, Francesco; Lozanski, Gerard; Parikh, Sameer A; Park, Jae H; Polliack, Aaron; Quest, Graeme; Robak, Tadeusz; Rogers, Kerry A; Saven, Alan; Seymour, John F; Tadmor, Tamar; Tallman, Martin S; Tam, Constantine S; Thompson, Philip A; Troussard, Xavier; Zent, Clive S; Zenz, Thorsten; Zinzani, Pier Luigi; Wörmann, Bernhard; Rai, Kanti; Grever, Michael.
Afiliación
  • Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. fravandi@mdanderson.org.
  • Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Tiacci E; Institute of Hematology, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.
  • Andritsos L; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
  • Banerji V; Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Barrientos JC; CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada.
  • Bhat SA; Feinstein Institutes for Medical Research and Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA.
  • Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Broccoli A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Call T; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"; and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Chihara D; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Dearden C; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Demeter J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Dietrich S; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Else M; Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Epperla N; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Falini B; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Forconi F; Institute of Hematology, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.
  • Gladstone DE; School of Cancer Sciences, Cancer Research UK Southampton Centre, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Gozzetti A; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, UK.
  • Iyengar S; Johns Hopkins Kimmel Cancer Center Baltimore, Baltimore, MD, USA.
  • Johnston JB; Dept. of Medicine, Surgery and Neurosciences, University of Siena, Policlinico S. Maria alle Scotte-, Siena, Italy.
  • Jorgensen J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Juliusson G; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
  • Lauria F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lozanski G; Lund University Stem Cell Center, Lund, Sweden.
  • Parikh SA; University of Siena, Siena, Italy.
  • Park JH; Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA.
  • Polliack A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Quest G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Robak T; Hadassah University Hospital, Jerusalem, Israel.
  • Rogers KA; Kingston Health Sciences Centre, Canada, Canada.
  • Saven A; Department of Hematology, Medical University of Lodz, Lodz, Poland.
  • Seymour JF; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Tadmor T; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA.
  • Tallman MS; Haematology Department, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.
  • Tam CS; Hematology Unit, Bnai Zion Medical Center; and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Thompson PA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Troussard X; Department of Haematology, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Zent CS; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zenz T; Department of Hematology, Centre Hospitalier Universitaire Cote de Nacre, Caen, France.
  • Zinzani PL; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Wörmann B; Dept. of Medical Oncology and Haematology, University Hospital Zürich and University of Zurich (UZH), Zurich, Switzerland.
  • Rai K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"; and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Grever M; The Charité - Universitätsmedizin Berlin, Berlin, Germany.
Blood Cancer J ; 12(12): 165, 2022 12 13.
Article en En | MEDLINE | ID: mdl-36509740
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia de Células Pilosas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia de Células Pilosas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos